Labcorp is raising its 2026 guidance, buoyed by demand across its diagnostics and central laboratory businesses. | Labcorp is ...
Hosted on MSN
Labcorp lifts 2026 forecast after strong Q1 results
Labcorp posted first-quarter 2026 revenue of $3.54 billion, up 5.8% year over year, and adjusted earnings per share of $4.25, exceeding prior-year results. The company raised its full-year revenue and ...
BURLINGTON, N.C., April 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the first quarter ...
(1) 2025 Updated guidance includes an impact from foreign currency translation of 0.4%. (2) Enterprise level revenue is presented net of intersegment transaction eliminations. (3) 2025 Updated ...
Q1 2026 earnings call: revenue +6%, EPS +11%, margin gains and raised 2026 guidance amid policy risks (PAMA/ACA).
With me today are Adam Schechter, our Chairman and Chief Executive Officer; and Julia Wang, our Executive Vice President and ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, the only companion ...
Labcorp Plasma Detect is the first clinically validated, whole-genome sequencing MRD solution for early-stage colon cancer The Labcorp Plasma Detect integrated whole-genome sequencing sample-to-report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results